Needham analyst Mayank Tandon maintains LendingTree (NASDAQ:TREE) with a Buy and raises the price target from $32 to $45.
Piper Sandler Maintains Overweight on Harpoon Therapeutics, Lowers Price Target to $7
Piper Sandler analyst Joseph Catanzaro maintains Harpoon Therapeutics (NASDAQ:HARP) with a Overweight and lowers the price target from $9 to $7.